3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
2
Breast Neoplasms
2
Stress Disorders, Post-Traumatic
1
Sleep Wake Disorders
1
Prostatic Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Lymphoma, Follicular
1
Leukemia, Hairy Cell
1
Leukemia
1
Fatigue
1
Depression
1
Colonic Neoplasms
1
Cardiotoxicity
1
Anxiety Disorders
1
Interventions
Modafinil
14
Surveys and Questionnaires
6
Methylphenidate
6
Yoga
4
Educational Status
3
Ultraviolet Therapy
2
Therapeutics
2
Sugars
2
Palliative Care
2
Donepezil
2
Dexamethasone
2
Calcium Dobesilate
2
Asian ginseng
2
Acceptance and Commitment Therapy
2
testosterone enanthate
1
testosterone 17 beta-cypionate
1
regorafenib
1
ofatumumab
1
exemestane
1
eicosapentaenoic acid ethyl ester
1
eicosapentaenoic acid ethanolamide
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
coenzyme Q10
1
caffeine, sodium benzoate drug combination
1
auricularum
1
Vitamin E
1
Triptorelin Pamoate
1
Transcranial Magnetic Stimulation
1
Transcranial Direct Current Stimulation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Fatigue
×
Exercise Test
×
Clear all
NCT00819208
2026-04-24
CHALLENGE
Canadian Cancer Trials Group
Phase NA
Completed
889 enrolled
9 charts